Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
[306 Pages Report] The HIV diagnostics market is anticipated to record a steady CAGR of 7.9% during the period 2022 to 2032.
During the forecast period, the HIV diagnostics market is predicted to rise from US$ 3.0 Billion in 2022 to US$ 6.4 Billion in 2032.
A favorable regulatory environment and substantial investment in Research and Development activities by market participants for the development of improved quality HIV testing kits for home use are likely to propel the HIV diagnostics market growth.
The demand for HIV diagnostics is forecasted to grow due to factors such as the rising global prevalence of HIV/AIDS, as well as the rising number of blood transfusions and blood donations.
Attributes | Details |
---|---|
HIV Diagnostics Market CAGR (2022 to 2032) | 7.9% |
HIV Diagnostics Market Value (2022) | US$ 3.0 Billion |
HIV Diagnostics Market Value (2032) | US$ 6.4 Billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The COVID-19 outbreak had a negative impact on the HIV diagnostics market share. To combat community transmission of the COVID-19 virus, many parts of the world implemented preventive lockdowns. As a result, the sales of HIV diagnostic procedures and patient visits in healthcare institutions have decreased significantly, severely impacting the HIV diagnostics market growth.
A disruption in ART supply and preventive measures, according to a modeling exercise conducted by the WHO and UNAIDS for Sub-Saharan Africa, might increase HIV-related mortality and new infections across the region. Due to this factor, the demand for HIV diagnostics increased.
As a precaution, countries were asked to establish a strategy for maintaining HIV prevention and treatment services throughout the COVID-19 pandemic. Unless immediate action was taken to ensure a continuous supply of pharmaceuticals and access to preventative treatments, the nations' gains would be lost.
The demand for HIV diagnostics grew significantly in 2021 as the number of COVID-19 patients decreased. The sales of HIV diagnostic procedures in settings with lower risk of infection have increased as a result of healthcare facilities establishing standard operating practices and a lower death rate linked to COVID-19.
As a result of the shrinking COVID-19 patient population, the sales of HIV diagnostic procedures and overall market share are likely to increase significantly in the near future.
The demand for HIV diagnostics is growing as it detects the presence of the human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome. HIV diagnostics is accomplished by performing tests on serum, saliva, or urine samples.
The sales of HIV diagnostic procedures are anticipated to grow as these techniques aid in detecting antibodies, antigens, and RNA. Furthermore, the demand for HIV diagnostics is growing as people become more aware of HIV, the test's secrecy, and appropriate counselling. Due to these factors, the HIV diagnostics market is projected to grow rapidly.
The demand for HIV diagnostics tests is anticipated to grow as they are critical in the accurate diagnosis and management of a person's health. The HIV diagnostics market share is projected to rise as more HIV diagnostics tests become available around the world.
However, the high costs of Nucleic Acid Testing (NAT) and the lack of NAT mandates in underdeveloped nations are limiting the growth of the HIV diagnostics market expansion.
The demand for HIV diagnostics is projected to rise as they provide simple quick assays with visual testing, as well as easy-to-handle home sample collecting approaches that may be utilized by health care personnel and customers at home. These factors are responsible for boosting the sales of HIV diagnostic procedures and have paved the way for the HIV diagnostics market to grow.
The sales of HIV diagnostic procedures are anticipated to grow due to the benefits provided by point-of-care tools and kits and increased government initiatives.
Rapid HIV tests are often known as point-of-care (PoC) HIV tests. HIV diagnosis often entails pre-test counselling, HIV testing, and post-test counselling, with patients expected to return for test results at a later date.
While the patient is still in the lab for PoC HIV diagnosis, counselling and screening are done simultaneously. If necessary, confirmation tests are performed. Individuals are not obliged to return for their results because pre-test and post-test counselling are done at the same time in PoC testing, making it a very convenient alternative.
As a result of this, the demand for HIV diagnostics is projected to rise at a significant pace during the forecast period.
The sales of HIV diagnostics procedures are projected to rise as rapid HIV testing yields results in about 30 minutes, removing the stress of waiting for results. Undiagnosed HIV cases and those who have not returned for follow-up testing are the major reasons for rapid HIV testing.
The demand for HIV diagnostics improved PoC kits and equipment is increasing as a consequence of its multiple benefits, which is projected to aid in the growth of the HIV diagnostics market size in the coming years.
HIV Diagnostics Market:
Attributes | HIV Diagnostics Market |
---|---|
CAGR (2022 to 2032) | 7.9% |
Market Value (2026) | US$ 4.07 Billion |
Growth Factor | The rising global prevalence of HIV/AIDS, as well as the rising number of blood transfusions and blood donations. |
Opportunity | Due to multiple advantages, the demand for technologically advanced PoC kits and instruments is on the rise |
Key Trends | Key players' substantial investment in Research and Development efforts for the development of improved quality HIV testing kits for home use. |
STD Diagnostics Market:
Attributes | STD Diagnostics Market |
---|---|
CAGR (2022 to 2032) | 4.8% |
Market Value (2026) | US$ 121.09 Billion |
Growth Factor | Increased public awareness and patient education to drive market growth. |
Opportunity | Countries around the world are focused on implementing nationwide screening tests to boost STD diagnosis coverage. |
Key Trends | The change from conventional methods to molecular diagnostics for the detection of STDs. |
Point of Care Testing Market:
Attributes | Point of Care Testing Market |
---|---|
CAGR (2022 to 2032) | 7.4% |
Market Value (2026) | US$ 44.51 Billion |
Growth Factor | POCT services have grown in popularity as the prevalence of chronic diseases and acute infections has increased around the world. |
Opportunity | The demand for point-of-care tests for rapid diagnosis is growing due to their convenience of use, cost-effectiveness, and small product size. |
Key Trends | POCT compliance, safety, and usability have become increasingly important as the scope of use and penetration in developing economies has grown. |
According to the Centers for Disease Control and Prevention (CDC), people aged 13 to 64 should be tested for HIV at least once as part of a routine health check. As a result of this, the HIV diagnostics
The demand for HIV diagnostics is rising as HIV infection remains a major public health concern around the world. As a result, the sales of HIV diagnostic procedures are also predicted to rise as HIV diagnosis has become increasingly vital in order to prevent the disease from spreading further.
The global HIV diagnostics market is booming due to rising demand for rapid testing and point-of-care (PoC) HIV tests around the world. In addition, people's disposable income is increasing, which is encouraging the HIV diagnostics market growth.
Expanding government and private sector awareness campaigns regarding HIV diagnostics and testing processes, as well as the growing presence of various industry players in this region, are projected to have a beneficial impact on the demand for HIV diagnostics. Furthermore, the increasing use of point-of-care testing in numerous nations is likely to propel African countries to use HIV diagnostic tests.
The consumable sector accounted for the largest market share in the global HIV diagnosis market. Consumption of consumables such as assays, reagents, and kits is on the rise, which is propelling the HIV diagnostics market forward.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The hospital sector is expected to lead the HIV diagnostics market, by end-use, and grow at a CAGR of 7.2% over the projected period. Continuous technical developments in laboratory devices are likely to support segment expansion by improving testing outcomes.
With a CAGR of 7.0%, the body tests are predicted to account for the biggest proportion of the market by test type. This substantial percentage can be ascribed to advances in HIV diagnosis technology, increased HIV awareness, and increased blood donations.
Regions | CAGR (2022 to 2032) |
---|---|
USA Market | 7.4% |
UK Market | 6.7% |
China Market | 7.2% |
Japan Market | 6.2% |
South Korea Market | 5.5% |
Due to rising product approval in the area, North America is predicted to dominate the global HIV diagnostics market. The US Food and Treatment Administration (FDA) granted Vela Diagnostics de novo approval for its Sentosa SQ HIV-1 Genotyping Assay, which was created to detect HIV-1 genomic drug resistance mutations (DRMs).
Abbott Laboratories gained WHO Prequalification approval (WHO PQ) for m-PIMA HIV-1/2 VL, the first point-of-care viral load diagnostic test, in May 2019. The portable molecular point-of-care test is intended for use in resource-constrained environments. The product's prequalification status makes it eligible for purchase by United Nations organizations.
According to the European Centre for Disease Prevention and Control (ECDC) study from 2017, over 51 percent of all HIV cases in Europe were detected late in 2015, and around 28 percent had progressed HIV infection. Furthermore, in nine European nations, including Austria, Estonia, Greece, Italy, Latvia, Lithuania, Romania, Slovenia, and Sweden, the rate of late diagnoses was greater than 50%.
In 2021, the African HIV diagnostics market accounted for approximately 38% of the global market, and it is expected to continue to rise rapidly over the analyzed period. High rates of HIV infections in African countries due to rising rates of teenage pregnancy, and a lack of quality sex education are some of the primary drivers of regional HIV diagnostics market expansion.
The HIV diagnostics market is likely to be driven by rising knowledge of available HIV aids treatment options and cost-effective HIV medication therapy. However, the quick replacement of HIV-AIDS treatments and therapies by new drugs and therapies, as well as patient protection losses, are limiting the worldwide HIV diagnostics market's growth.
The growth of the HIV diagnostics market in Asia is likely to be led by developing countries such as India and China, which have growing demographics and economies. Furthermore, the global HIV diagnostics market is likely to benefit from increased knowledge about HIV-AIDS treatment and technological advancements in HIV-AIDS testing.
There are a few major competitors in the HIV diagnostics market. To stay competitive in the HIV diagnostics market, these companies are using a variety of growth tactics such as collaboration, acquisition & merger, partnership, and new launches.
Recent Developments in the HIV Diagnostics Market
The HIV diagnostics market is projected to register a CAGR of 7.9% during the period 2022 to 2032.
North America is predicted to dominate the global HIV diagnostics market.
The hospitals sector is expected to lead the HIV diagnostics market by end use.
The HIV diagnostics market is anticipated to grow from US$ 3.0 Billion in 2022 to US$ 6.4 Billion by 2032.
Asia Pacific (APAC) region has the highest growth potential in the HIV diagnostics market.
1. Executive Summary | HIV Diagnostics Market 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on HIV Diagnostics 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Million) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in Optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Patch Management Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032 6.1. Historical Market Analysis, 2015 to 2021 6.2. Current and Future Market Projections, 2022 to 2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021 7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Product, 2015 to 2021 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2022 to 2032 8.3.1. Consumables 8.3.2. Instruments 8.3.3. Software & Services 8.4. Market Attractiveness Analysis By Product 9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Test Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By Test Type, 2015 to 2021 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Test Type, 2022 to 2032 9.3.1. Antibody Tests 9.3.2. Viral Load Tests 9.3.3. CD4 Tests 9.3.4. Others 9.4. Market Attractiveness Analysis By Test Type 10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2021 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2032 10.3.1. Diagnostic Laboratories 10.3.2. Hospitals 10.3.3. Others 10.4. Market Attractiveness Analysis By End User 11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2021 11.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Asia Pacific 11.3.5. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 12.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 12.4.1. By Country 12.4.1.1. United States of America 12.4.1.2. Canada 12.4.1.3. Rest of North America 12.4.2. By Product 12.4.3. By End User 12.4.4. By Test Type 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Product 12.5.3. By End User 12.5.4. By Test Type 13. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 13.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Product 13.4.3. By End User 13.4.4. By Test Type 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product 13.5.3. By End User 13.5.4. By Test Type 14. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 14.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. France 14.4.1.3. United Kingdom 14.4.1.4. Italy 14.4.1.5. Benelux 14.4.1.6. Nordic Countries 14.4.1.7. Rest of Europe 14.4.2. By Product 14.4.3. By End User 14.4.4. By Test Type 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product 14.5.3. By End User 14.5.4. By Test Type 15. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 15.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.1.4. Rest of Asia Pacific 15.4.2. By Product 15.4.3. By End User 15.4.4. By Test Type 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product 15.5.3. By End User 15.5.4. By Test Type 16. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021 16.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032 16.4.1. By Country 16.4.1.1. GCC Countries 16.4.1.2. South Africa 16.4.1.3. Turkey 16.4.1.4. Rest of Middle East and Africa 16.4.2. By Product 16.4.3. By End User 16.4.4. By Test Type 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product 16.5.3. By End User 16.5.4. By Test Type 17. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. US Market Analysis 17.2.1. Value Proportion Analysis by Market Taxonomy 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.2.2.1. By Product 17.2.2.2. By End User 17.2.2.3. By Test Type 17.3. Canada Market Analysis 17.3.1. Value Proportion Analysis by Market Taxonomy 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.3.2.1. By Product 17.3.2.2. By End User 17.3.2.3. By Test Type 17.4. Mexico Market Analysis 17.4.1. Value Proportion Analysis by Market Taxonomy 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.4.2.1. By Product 17.4.2.2. By End User 17.4.2.3. By Test Type 17.5. Brazil Market Analysis 17.5.1. Value Proportion Analysis by Market Taxonomy 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.5.2.1. By Product 17.5.2.2. By End User 17.5.2.3. By Test Type 17.6. Germany Market Analysis 17.6.1. Value Proportion Analysis by Market Taxonomy 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.6.2.1. By Product 17.6.2.2. By End User 17.6.2.3. By Test Type 17.7. France Market Analysis 17.7.1. Value Proportion Analysis by Market Taxonomy 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.7.2.1. By Product 17.7.2.2. By End User 17.7.2.3. By Test Type 17.8. Italy Market Analysis 17.8.1. Value Proportion Analysis by Market Taxonomy 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.8.2.1. By Product 17.8.2.2. By End User 17.8.2.3. By Test Type 17.9. BENELUX Market Analysis 17.9.1. Value Proportion Analysis by Market Taxonomy 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.9.2.1. By Product 17.9.2.2. By End User 17.9.2.3. By Test Type 17.10. UK Market Analysis 17.10.1. Value Proportion Analysis by Market Taxonomy 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.10.2.1. By Product 17.10.2.2. By End User 17.10.2.3. By Test Type 17.11. Nordic Countries Market Analysis 17.11.1. Value Proportion Analysis by Market Taxonomy 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.11.2.1. By Product 17.11.2.2. By End User 17.11.2.3. By Test Type 17.12. China Market Analysis 17.12.1. Value Proportion Analysis by Market Taxonomy 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.12.2.1. By Product 17.12.2.2. By End User 17.12.2.3. By Test Type 17.13. Japan Market Analysis 17.13.1. Value Proportion Analysis by Market Taxonomy 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.13.2.1. By Product 17.13.2.2. By End User 17.13.2.3. By Test Type 17.14. South Korea Market Analysis 17.14.1. Value Proportion Analysis by Market Taxonomy 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.14.2.1. By Product 17.14.2.2. By End User 17.14.2.3. By Test Type 17.15. GCC Countries Market Analysis 17.15.1. Value Proportion Analysis by Market Taxonomy 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.15.2.1. By Product 17.15.2.2. By End User 17.15.2.3. By Test Type 17.16. South Africa Market Analysis 17.16.1. Value Proportion Analysis by Market Taxonomy 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.16.2.1. By Product 17.16.2.2. By End User 17.16.2.3. By Test Type 17.17. Turkey Market Analysis 17.17.1. Value Proportion Analysis by Market Taxonomy 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032 17.17.2.1. By Product 17.17.2.2. By End User 17.17.2.3. By Test Type 17.17.3. Competition Landscape and Player Concentration in the Country 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional Footprint of Players 18.4.2. Product Footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. Siemens Healthineers 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Sales Footprint 19.3.1.4. Strategy Overview 19.3.2. F. Hoffmann-La Roche Ltd 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Sales Footprint 19.3.2.4. Strategy Overview 19.3.3. Abbott Laboratories 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Sales Footprint 19.3.3.4. Strategy Overview 19.3.4. Danaher Corporation 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Sales Footprint 19.3.4.4. Strategy Overview 19.3.5. Thermo-Fisher Scientific Inc 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Sales Footprint 19.3.5.4. Strategy Overview 19.3.6. Merck KGaA 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Sales Footprint 19.3.6.4. Strategy Overview 19.3.7. Becton, Dickinson & Company 19.3.7.1. Overview 19.3.7.2. Product Portfolio 19.3.7.3. Sales Footprint 19.3.7.4. Strategy Overview 19.3.8. Hologic Inc 19.3.8.1. Overview 19.3.8.2. Product Portfolio 19.3.8.3. Sales Footprint 19.3.8.4. Strategy Overview 19.3.9. Bio-Rad Laboratories 19.3.9.1. Overview 19.3.9.2. Product Portfolio 19.3.9.3. Sales Footprint 19.3.9.4. Strategy Overview 19.3.10. Alere Inc 19.3.10.1. Overview 19.3.10.2. Product Portfolio 19.3.10.3. Sales Footprint 19.3.10.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million), By Product, 2015 to 2021 Table 2: Global Market Value (US$ Million), By Product, 2022 to 2032 Table 3: Global Market Value (US$ Million), By End User, 2015 to 2021 Table 4: Global Market Value (US$ Million), By End User, 2022 to 2032 Table 5: Global Market Value (US$ Million), By Test Type, 2015 to 2021 Table 6: Global Market Value (US$ Million), By Test Type, 2022 to 2032 Table 7: Global Market, By Region, 2015 to 2021 Table 8: Global Market, By Region, 2022 to 2032 Table 9: North America Market Value (US$ Million), By Product, 2015 to 2021 Table 10: North America Market Value (US$ Million), By Product, 2022 to 2032 Table 11: North America Market Value (US$ Million), By End User, 2015 to 2021 Table 12: North America Market Value (US$ Million), By End User, 2022 to 2032 Table 13: North America Market Value (US$ Million), By Test Type, 2015 to 2021 Table 14: North America Market Value (US$ Million), By Test Type, 2022 to 2032 Table 15: North America Market, By Country, 2015 to 2021 Table 16: North America Market, By Country, 2022 to 2032 Table 17: Latin America Market Value (US$ Million), By Product, 2015 to 2021 Table 18: Latin America Market Value (US$ Million), By Product, 2022 to 2032 Table 19: Latin America Market Value (US$ Million), By End User, 2015 to 2021 Table 20: Latin America Market Value (US$ Million), By End User, 2022 to 2032 Table 21: Latin America Market Value (US$ Million), By Test Type, 2015 to 2021 Table 22: Latin America Market Value (US$ Million), By Test Type, 2022 to 2032 Table 23: Latin America Market, By Country, 2015 to 2021 Table 24: Latin America Market, By Country, 2022 to 2032 Table 25: Europe Market Value (US$ Million), By Product, 2015 to 2021 Table 26: Europe Market Value (US$ Million), By Product, 2022 to 2032 Table 27: Europe Market Value (US$ Million), By End User, 2015 to 2021 Table 28: Europe Market Value (US$ Million), By End User, 2022 to 2032 Table 29: Europe Market Value (US$ Million), By Test Type, 2015 to 2021 Table 30: Europe Market Value (US$ Million), By Test Type, 2022 to 2032 Table 31: Europe Market, By Country, 2015 to 2021 Table 32: Europe Market, By Country, 2022 to 2032 Table 33: Asia Pacific Market Value (US$ Million), By Product, 2015 to 2021 Table 34: Asia Pacific Market Value (US$ Million), By Product, 2022 to 2032 Table 35: Asia Pacific Market Value (US$ Million), By End User, 2015 to 2021 Table 36: Asia Pacific Market Value (US$ Million), By End User, 2022 to 2032 Table 37: Asia Pacific Market Value (US$ Million), By Test Type, 2015 to 2021 Table 38: Asia Pacific Market Value (US$ Million), By Test Type, 2022 to 2032 Table 39: Asia Pacific Market, By Country, 2015 to 2021 Table 40: Asia Pacific Market, By Country, 2022 to 2032 Table 41: MEA Market Value (US$ Million), By Product, 2015 to 2021 Table 42: MEA Market Value (US$ Million), By Product, 2022 to 2032 Table 43: MEA Market Value (US$ Million), By End User, 2015 to 2021 Table 44: MEA Market Value (US$ Million), By End User, 2022 to 2032 Table 45: MEA Market Value (US$ Million), By Test Type, 2015 to 2021 Table 46: MEA Market Value (US$ Million), By Test Type, 2022 to 2032 Table 47: MEA Market, By Country, 2015 to 2021 Table 48: MEA Market, By Country, 2022 to 2032 Table 49: Global Market Incremental $ Opportunity, By Product, 2015 to 2021 Table 50: Global Market Incremental $ Opportunity, By End User, 2022 to 2032 Table 51: Global Market Incremental $ Opportunity, By Test Type, 2015 to 2021 Table 52: Global Market Incremental $ Opportunity, By Region, 2022 to 2032 Table 53: North America Market Incremental $ Opportunity, By Product, 2015 to 2021 Table 54: North America Market Incremental $ Opportunity, By End User, 2022 to 2032 Table 55: North America Market Incremental $ Opportunity, By Test Type, 2015 to 2021 Table 56: North America Market Incremental $ Opportunity, By Country, 2022 to 2032 Table 57: Latin America Market Incremental $ Opportunity, By Product, 2015 to 2021 Table 58: Latin America Market Incremental $ Opportunity, By End User, 2022 to 2032 Table 59: Latin America Market Incremental $ Opportunity, By Test Type, 2015 to 2021 Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032 Table 61: Europe Market Incremental $ Opportunity, By Product, 2015 to 2021 Table 62: Europe Market Incremental $ Opportunity, By End User, 2022 to 2032 Table 63: Europe Market Incremental $ Opportunity, By Test Type, 2015 to 2021 Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032 Table 65: Asia Pacific Market Incremental $ Opportunity, By Product, 2015 to 2021 Table 66: Asia Pacific Market Incremental $ Opportunity, By End User, 2022 to 2032 Table 67: Asia Pacific Market Incremental $ Opportunity, By Test Type, 2015 to 2021 Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 to 2032 Table 69: MEA Market Incremental $ Opportunity, By Product, 2015 to 2021 Table 70: MEA Market Incremental $ Opportunity, By End User, 2022 to 2032 Table 71: MEA Market Incremental $ Opportunity, By Test Type, 2015 to 2021 Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 to 2032
Figure 1: Global Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 2: Global Market Absolute $ Historical Gain (2015 to 2021) and Opportunity (2022 to 2032), US$ Million Figure 3: Global Market Share, By Product, 2022 & 2032 Figure 4: Global Market Y-o-Y Growth Projections, By Product - 2022 to 2032 Figure 5: Global Market Attractiveness Index, By Product - 2022 to 2032 Figure 6: Global Market Share, By End User, 2022 & 2032 Figure 7: Global Market Y-o-Y Growth Projections, By End User - 2022 to 2032 Figure 8: Global Market Attractiveness Index, By End User - 2022 to 2032 Figure 9: Global Market Share, By Test Type, 2022 & 2032 Figure 10: Global Market Y-o-Y Growth Projections, By Test Type - 2022 to 2032 Figure 11: Global Market Attractiveness Index, By Test Type - 2022 to 2032 Figure 12: Global Market Share, By Region, 2022 & 2032 Figure 13: Global Market Y-o-Y Growth Projections, By Region - 2022 to 2032 Figure 14: Global Market Attractiveness Index, By Region - 2022 to 2032 Figure 15: North America Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 16: North America Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million Figure 17: North America Market Share, By Product, 2022 & 2032 Figure 18: North America Market Y-o-Y Growth Projections, By Product - 2022 to 2032 Figure 19: North America Market Attractiveness Index, By Product - 2022 to 2032 Figure 20: North America Market Share, By End User, 2022 & 2032 Figure 21: North America Market Y-o-Y Growth Projections, By End User - 2022 to 2032 Figure 22: North America Market Attractiveness Index, By End User - 2022 to 2032 Figure 23: North America Market Share, By Test Type, 2022 & 2032 Figure 24: North America Market Y-o-Y Growth Projections, By Test Type - 2022 to 2032 Figure 25: North America Market Attractiveness Index, By Test Type - 2022 to 2032 Figure 26: North America Market Share, By Country, 2022 & 2032 Figure 27: North America Market Y-o-Y Growth Projections, By Country - 2022 to 2032 Figure 28: North America Market Attractiveness Index, By Country - 2022 to 2032 Figure 29: Latin America Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 30: Latin America Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million Figure 31: Latin America Market Share, By Product, 2022 & 2032 Figure 32: Latin America Market Y-o-Y Growth Projections, By Product - 2022 to 2032 Figure 33: Latin America Market Attractiveness Index, By Product - 2022 to 2032 Figure 34: Latin America Market Share, By End User, 2022 & 2032 Figure 35: Latin America Market Y-o-Y Growth Projections, By End User - 2022 to 2032 Figure 36: Latin America Market Attractiveness Index, By End User - 2022 to 2032 Figure 37: Latin America Market Share, By Test Type, 2022 & 2032 Figure 38: Latin America Market Y-o-Y Growth Projections, By Test Type - 2022 to 2032 Figure 39: Latin America Market Attractiveness Index, By Test Type - 2022 to 2032 Figure 40: Latin America Market Share, By Country, 2022 & 2032 Figure 41: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 2032 Figure 42: Latin America Market Attractiveness Index, By Country - 2022 to 2032 Figure 43: Europe Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 44: Europe Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million Figure 45: Europe Market Share, By Product, 2022 & 2032 Figure 46: Europe Market Y-o-Y Growth Projections, By Product - 2022 to 2032 Figure 47: Europe Market Attractiveness Index, By Product - 2022 to 2032 Figure 48: Europe Market Share, By End User, 2022 & 2032 Figure 49: Europe Market Y-o-Y Growth Projections, By End User - 2022 to 2032 Figure 50: Europe Market Attractiveness Index, By End User - 2022 to 2032 Figure 51: Europe Market Share, By Test Type, 2022 & 2032 Figure 52: Europe Market Y-o-Y Growth Projections, By Test Type - 2022 to 2032 Figure 53: Europe Market Attractiveness Index, By Test Type - 2022 to 2032 Figure 54: Europe Market Share, By Country, 2022 & 2032 Figure 55: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 2032 Figure 56: Europe Market Attractiveness Index, By Country - 2022 to 2032 Figure 57: MEA Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 58: MEA Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million Figure 59: MEA Market Share, By Product, 2022 & 2032 Figure 60: MEA Market Y-o-Y Growth Projections, By Product - 2022 to 2032 Figure 61: MEA Market Attractiveness Index, By Product - 2022 to 2032 Figure 62: MEA Market Share, By End User, 2022 & 2032 Figure 63: MEA Market Y-o-Y Growth Projections, By End User - 2022 to 2032 Figure 64: MEA Market Attractiveness Index, By End User - 2022 to 2032 Figure 65: MEA Market Share, By Test Type, 2022 & 2032 Figure 66: MEA Market Y-o-Y Growth Projections, By Test Type - 2022 to 2032 Figure 67: MEA Market Attractiveness Index, By Test Type - 2022 to 2032 Figure 68: MEA Market Share, By Country, 2022 & 2032 Figure 69: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 2032 Figure 70: MEA Market Attractiveness Index, By Country - 2022 to 2032 Figure 71: Asia Pacific Market Value (US$ Million) and Year-on-Year Growth, 2015 to 2032 Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2015 to 2021) and Forecast Period (2022 to 2032), US$ Million Figure 73: Asia Pacific Market Share, By Product, 2022 & 2032 Figure 74: Asia Pacific Market Y-o-Y Growth Projections, By Product - 2022 to 2032 Figure 75: Asia Pacific Market Attractiveness Index, By Product - 2022 to 2032 Figure 76: Asia Pacific Market Share, By End User, 2022 & 2032 Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By End User - 2022 to 2032 Figure 78: Asia Pacific Market Attractiveness Index, By End User - 2022 to 2032 Figure 79: Asia Pacific Market Share, By Test Type, 2022 & 2032 Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Test Type - 2022 to 2032 Figure 81: Asia Pacific Market Attractiveness Index, By Test Type - 2022 to 2032 Figure 82: Asia Pacific Market Share, By Country, 2022 & 2032 Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country - 2022 to 2032 Figure 84: Asia Pacific Market Attractiveness Index, By Country - 2022 to 2032 Figure 85: US Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 86: US Market Share, By Product, 2021 Figure 87: US Market Share, By End User, 2021 Figure 88: US Market Share, By Test Type, 2021 Figure 89: Canada Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 90: Canada Market Share, By Product, 2021 Figure 91: Canada Market Share, By End User, 2021 Figure 92: Canada Market Share, By Test Type, 2021 Figure 93: Brazil Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 94: Brazil Market Share, By Product, 2021 Figure 95: Brazil Market Share, By End User, 2021 Figure 96: Brazil Market Share, By Test Type, 2021 Figure 97: Mexico Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 98: Mexico Market Share, By Product, 2021 Figure 99: Mexico Market Share, By End User, 2021 Figure 100: Mexico Market Share, By Test Type, 2021 Figure 101: Germany Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 102: Germany Market Share, By Product, 2021 Figure 103: Germany Market Share, By End User, 2021 Figure 104: Germany Market Share, By Test Type, 2021 Figure 105: UK Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 106: UK Market Share, By Product, 2021 Figure 107: UK Market Share, By End User, 2021 Figure 108: UK Market Share, By Test Type, 2021 Figure 109: France Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 110: France Market Share, By Product, 2021 Figure 111: France Market Share, By End User, 2021 Figure 112: France Market Share, By Test Type, 2021 Figure 113: Italy Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 114: Italy Market Share, By Product, 2021 Figure 115: Italy Market Share, By End User, 2021 Figure 116: Italy Market Share, By Test Type, 2021 Figure 117: BENELUX Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 118: BENELUX Market Share, By Product, 2021 Figure 119: BENELUX Market Share, By End User, 2021 Figure 120: BENELUX Market Share, By Test Type, 2021 Figure 121: Nordic Countries Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 122: Nordic Countries Market Share, By Product, 2021 Figure 123: Nordic Countries Market Share, By End User, 2021 Figure 124: Nordic Countries Market Share, By Test Type, 2021 Figure 125: China Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 126: China Market Share, By Product, 2021 Figure 127: China Market Share, By End User, 2021 Figure 128: China Market Share, By Test Type, 2021 Figure 129: Japan Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 130: Japan Market Share, By Product, 2021 Figure 131: Japan Market Share, By End User, 2021 Figure 132: Japan Market Share, By Test Type, 2021 Figure 133: South Korea Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 134: South Korea Market Share, By Product, 2021 Figure 135: South Korea Market Share, By End User, 2021 Figure 136: South Korea Market Share, By Test Type, 2021 Figure 137: GCC Countries Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 138: GCC Countries Market Share, By Product, 2021 Figure 139: GCC Countries Market Share, By End User, 2021 Figure 140: GCC Countries Market Share, By Test Type, 2021 Figure 141: South Africa Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 142: South Africa Market Share, By Product, 2021 Figure 143: South Africa Market Share, By End User, 2021 Figure 144: South Africa Market Share, By Test Type, 2021 Figure 145: Turkey Market Value (US$ Million) and Forecast, 2022 to 2032 Figure 146: Turkey Market Share, By Product, 2021 Figure 147: Turkey Market Share, By End User, 2021 Figure 148: Turkey Market Share, By Test Type, 2021
Recommendations
Explore Healthcare Insights
View Reports